Significance
The elderly exhibit susceptibility to many infectious agents, including S. pneumoniae. A robust acute inflammatory response to S. pneumoniae is associated with severe disease. S. pneumoniae triggers canonical autophagy in nonprofessional phagocytes, but its role in macrophages is largely unexplored. We found that BMDMs utilize LAP, rather than canonical autophagy, to both eliminate S. pneumoniae and modulate inflammation. Notably, compared to young BMDMs, aged BMDMs were deficient in LAP, resulting in compromised bacterial killing and enhanced proinflammatory responses. Thus, S. pneumoniae triggers LAP in BMDMs, a process that controls both microbial numbers and tissue-damaging inflammation. Importantly, LAP diminishes with age and may contribute to the observed susceptibility of the elderly to many infectious diseases.
Keywords: LC3-associated phagocytosis, bone-marrow-derived macrophages, Streptococcus pneumoniae, aging, autophagy
Abstract
Streptococcus pneumoniae is a leading cause of pneumonia and invasive disease, particularly, in the elderly. S. pneumoniae lung infection of aged mice is associated with high bacterial burdens and detrimental inflammatory responses. Macrophages can clear microorganisms and modulate inflammation through two distinct lysosomal trafficking pathways that involve 1A/1B-light chain 3 (LC3)-marked organelles, canonical autophagy, and LC3-associated phagocytosis (LAP). The S. pneumoniae pore-forming toxin pneumolysin (PLY) triggers an autophagic response in nonphagocytic cells, but the role of LAP in macrophage defense against S. pneumoniae or in age-related susceptibility to infection is unexplored. We found that infection of murine bone-marrow-derived macrophages (BMDMs) by PLY-producing S. pneumoniae triggered Atg5- and Atg7-dependent recruitment of LC3 to S. pneumoniae-containing vesicles. The association of LC3 with S. pneumoniae-containing phagosomes required components specific for LAP, such as Rubicon and the NADPH oxidase, but not factors, such as Ulk1, FIP200, or Atg14, required specifically for canonical autophagy. In addition, S. pneumoniae was sequestered within single-membrane compartments indicative of LAP. Importantly, compared to BMDMs from young (2-mo-old) mice, BMDMs from aged (20- to 22-mo-old) mice infected with S. pneumoniae were not only deficient in LAP and bacterial killing, but also produced higher levels of proinflammatory cytokines. Inhibition of LAP enhanced S. pneumoniae survival and cytokine responses in BMDMs from young but not aged mice. Thus, LAP is an important innate immune defense employed by BMDMs to control S. pneumoniae infection and concomitant inflammation, one that diminishes with age and may contribute to age-related susceptibility to this important pathogen.
Streptococcus pneumoniae (pneumococcus) commonly colonizes the nasopharynx asymptomatically but is also capable of infecting the lower respiratory tract to cause pneumonia and spreading to the bloodstream to cause septicemia and meningitis (1). Susceptibility to pneumonia and invasive disease caused by S. pneumoniae is remarkably higher in individuals aged 65 and over, leading to high rates of mortality and morbidity in the elderly population (1, 2). In countries, such as the United States and Japan, deaths due to pneumococcal pneumonia have been on the rise in parallel with the rapid growth in the elderly population (3, 4).
A hallmark of pneumococcal pneumonia is a rapid and exuberant response by immune cells, such as neutrophils and macrophages. This innate immune response to S. pneumoniae lung infection is critical for pathogen clearance and the control of disease (5–7). Deficiencies in the number or function of innate phagocytic cells, such as neutropenia (8) or macrophage phagocytic receptor defects (9–12), lead to diminished pneumococcal clearance and increased risk of invasive pneumococcal disease in both mouse models and humans. Phagocytic activity in alveolar macrophages is important during early responses to subclinical infections (13–15), and during moderate S. pneumoniae lung infection, newly generated monocytes eggress from the bone marrow and migrate into the lungs, differentiating into monocyte-derived alveolar macrophages (16). In addition to directly eliminating the invading microbe, macrophages secrete key cytokines, such as tumor necrosis factor (TNF), interleukin-1β (IL-1β), and interleukin-6 (IL-6), that regulate effector cell functions and pulmonary inflammation (17–19).
Although an innate immune response is critical for pathogen clearance, poorly controlled inflammation can lead to tissue damage and mortality (20, 21). For example, in murine models, neutrophilic infiltration can enhance pulmonary damage and disrupt epithelial barrier function, leading to bacteremia and mortality (22–25). Macrophages are critical not only in regulating the early inflammatory response, but are also crucial for curtailing inflammation during the resolution phase of infection to limit tissue damage and promote healing (26, 27).
Elderly individuals have higher baseline and induced levels of inflammation, a phenomenon termed inflammaging (28), that contributes to many age-associated pathological conditions, including increased susceptibility to a variety of infectious diseases, such as S. pneumoniae infection (7, 28–30). S. pneumoniae-induced inflammation, characterized by increased levels of chemokines, proinflammatory cytokines, and decreased anti-inflammatory cytokines, such as IL-10, is enhanced in the elderly (29, 31) as well as in aged mice (32, 33) and correlates with ineffective immune responses. Age-related chronic exposure to TNF-α, for instance, dampens macrophage-mediated S. pneumoniae clearance during lung infection (34), and NLR family pyrin domain containing 3 inflammasome activation in macrophages diminishes upon aging in mice (35). However, the age-related changes in macrophage effector functions leading to diminished clearance of S. pneumoniae are incompletely understood.
One important means of macrophage-mediated pathogen clearance is1A/1B-light chain-3 (LC3)-associated phagocytosis (LAP), a process by which cells target phagocytosed extracellular particles for efficient degradation (36–38). LAP combines the molecular machineries of phagocytosis and autophagy, resulting in the conjugation of the autophagic marker, the microtubule-associated protein LC3, to phosphatidylethanolamine on the phagosomal membrane, generating so-called “LAPosomes” that undergo facilitated fusion with lysosomes (38, 39). Canonical autophagy targets cytoplasmic components, such as damaged subcellular organelles and intracellular microbes for sequestration into double-membrane autophagic vesicles (40, 41). In contrast, LAPosomes retain the single-membrane nature of phagosomes, and their formation requires overlapping but nonidentical genes compared to canonical autophagy (42). In addition to enabling efficient degradation of phagocytosed bacteria, LAP also plays important immune regulatory roles, such as in curtailing proinflammatory cytokine production during the subsequent innate immune response (39, 43). Indeed, the LAP-mediated microbial defense and immunomodulatory functions work together to limit tissue damage and restore homeostasis (38).
S. pneumoniae triggers canonical autophagy in epithelial cells and fibroblasts, and bacteria can be found in double-membrane vacuoles whose formation is dependent on autophagic machinery (44). Many bacterial pathogens that induce autophagy produce pore-forming toxins, which can damage endosomal membranes, thus, recruiting autophagic machinery to engulf injured organelles (45). Pneumococcus-induced autophagy is dependent on the cholesterol-dependent pore-forming toxin pneumolysin (PLY), which triggers the autophagic delivery of S. pneumoniae to lysosomes and results in bacterial killing (44, 46). Recently, a kinetic examination of S. pneumoniae-targeting autophagy in fibroblasts demonstrated that canonical autophagy was preceded by early and rapid PLY-dependent LAP (47). However, the requirements for this process were somewhat different from LAP in macrophages, and the pneumococcus-containing LAPosomes did not promote bacterial clearance but required subsequent transition to canonical autophagy to reduce bacterial numbers (46, 47).
In the current study, we found that S. pneumoniae infection of murine bone-marrow-derived macrophages (BMDMs) induces LAP in a PLY-dependent manners and that age-related defects in BMDM LAP contributed to diminished bactericidal activity and enhanced proinflammatory cytokine production. Our results suggest that PLY-induced LAP promotes bacterial clearance, and age-associated dysregulation of this process may contribute to enhanced bacterial survival, poorly regulated inflammation, and increased susceptibility to invasive pneumococcal disease.
Results
S. pneumoniae Triggers PLY-Dependent Lipidation of LC3, Which Is Recruited to Internalized Bacteria.
To determine if the autophagic process identified in nonimmune cells also occurs in macrophages, we infected murine BMDMs with S. pneumoniae. We found that infection of BMDM rapidly induced conversion of LC3-I to its vesicle-bound form LC3-II, indicating onset of autophagy or an autophagy-related process (Fig. 1A). To identify if specific bacterial components of S. pneumoniae, such as the cholesterol-dependent pore-forming cytolysin PLY, were required to trigger LC3 lipidation, we infected BMDMs with several S. pneumoniae mutants, including strains lacking pneumococcal surface protein A (ΔpspA), pneumococcal surface protein C (ΔpspC), capsule (Δcps), or PLY (Δply). We found that the PLY-deficient strain failed to trigger LC3-I conversion to LC3-II (Fig. 1A).
To examine PLY-mediated autophagic processes in an experimental model that permits gene silencing approaches, we utilized murine RAW264.7 macrophages (48). As predicted, serum starvation, a documented inducer of autophagy (49), resulted in production of LC3-II (Fig. 1B). S. pneumoniae infection also triggered LC3-II production in these macrophages in a manner dependent on the multiplicity of infection (MOI) (Fig. 1B). Fluorescent microscopic examination of S. pneumoniae-infected cells that stably express a green fluorescent protein (GFP)-tagged LC3 protein (GFP-LC3) revealed that LC3 colocalized with ∼35% of intracellular S. pneumoniae within the first 0.5 h with colocalization gradually diminishing after 1 h (Fig. 1 C and D). PLY-deficient mutants of S. pneumoniae strains TIGR4 or D39 were significantly diminished for LC3 colocalization compared to wild-type (WT), and marker rescue of S. pneumoniae strain D39Δply reversed this defect (Fig. 1E). The endopeptidase PepO has been implicated in stimulation of peritoneal derived macrophage autophagy by S. pneumoniae strain D39 (50), but the inability of a PLY-deficient strain D39 to trigger LC3 colocalization indicates that PepO is insufficient to initiate the autophagic process. For the experiments described below, we utilized strain TIGR4. As expected, gene silencing of Atg5 and Atg7, which encode proteins required for canonical autophagy and LAP, abolished both rapamycin (Rapa)-induced autophagic responses (SI Appendix, Fig. S1 A and B) as well as LC3 colocalization with S. pneumoniae (Fig. 1 F and G and SI Appendix, Fig. S1 C and D) as did chemical inhibition with the PI3K inhibitor 3-methyladenine (3-MA) (Fig. 1H and SI Appendix, Fig. S1E). Similarly, BMDMs lacking Atg7 exhibited reduced recruitment of GFP-LC3 to S. pneumoniae, demonstrating that the requirement for ATG7 for LC3 colocalization with S. pneumoniae in primary cells (Fig. 1I and SI Appendix, Fig. S1F). Thus, S. pneumoniae infection triggers a PLY-dependent LC3 recruitment to internalized bacteria in BMDMs, an autophagic process that requires ATG5, ATG7, and PI3K.
S. pneumoniae Triggers LAP and Not Canonical Autophagy in Murine BMDMs.
LC3 conversion and recruitment to intracellular compartments occurs in both canonical autophagy and nonclassical processes, such as LAP. LC3 recruitment in canonical autophagy depends upon initiation and elongation of the phagophore and can take up to several hours to accomplish, whereas in LAP, recruitment has been observed as early as 15 min after infection and can wane after 1 h (40, 41). In our case, we observed a dramatic increase in LC3 recruitment to S. pneumoniae vesicles by 0.5-h postinfection that decreased after 1 h (Fig. 1 C and D), which led us to postulate that LAP rather than canonical autophagy drives LC3 recruitment to S. pneumoniae. To test our hypothesis, we initially examined the involvement of reactive oxygen species (ROS) production machinery in S. pneumoniae triggered LC3 recruitment as PLY induces the production of intracellular ROS in human neutrophils (51), and generation of ROS by the NADPH oxidase is often required for LAP (42, 52). We found that S. pneumoniae and zymosan (Zymo), which induces LAP (52), colocalized with both membrane (NOX2; gp91phox) and cytosolic (p40phox) components of the NADPH oxidase (Fig. 2 A and B) and that infection with S. pneumoniae triggered a significant increase in ROS (Fig. 2C). Pretreatment of RAW264.7 cells with the NADPH oxidase inhibitor diphenyleneiodonium (DPI) significantly reduced LC3 recruitment to both Zymo and S. pneumoniae (Fig. 2D). Although PLY was required for the conversion of LC3-I to LC3-II (Fig. 1A) and for colocalization of LC3 with internalized S. pneumoniae, PLY is not required for ROS production (53). Here, we confirmed this result (SI Appendix, Fig. S2A) and further showed that PLY was also not required for bacterial colocalization with NOX2 (gp91phox; SI Appendix, Fig. S2B), suggesting that S. pneumoniae may also trigger ROS production by mechanisms not related to phagosomal damage.
Next, we characterized the roles of several proteins that are differentially required for canonical autophagy and LAP for their involvement in LC3 recruitment to intracellular S. pneumoniae in BMDMs and RAW264.7 macrophages. First, in contrast to LAP, canonical autophagy requires inactivation of the mTOR pathway and results in dephosphorylation of the mTOR substrate p70S6K (54). Indeed, p70S6K was dephosphorylated in BMDMs treated with Rapa, a known inducer of canonical autophagy but not with exposure to Zymo or S. pneumoniae (Fig. 3A). In RAW264.7 cells, silencing of Ulk1, FIP200, and Atg14, all of which are required for canonical autophagy but not LAP, eliminated Rapa-induced autophagic responses as predicted (SI Appendix, Fig. S3 A and B) but did not affect LC3 colocalization with S. pneumoniae (Fig. 3 B–D and SI Appendix, Fig. S3 C–E). In contrast, silencing Rubicon, which is specifically required for LAP (52, 55, 56), did not impact Rapa-induced autophagy (SI Appendix, Fig. S3 A and B) but inhibited LC3 colocalization to S. pneumoniae (Fig. 3B and SI Appendix, Fig. S3C). Similarly, KO genes uniquely required for LAP, such as Rubicon and Nox2 (54) significantly reduced LC3 recruitment to S. pneumoniae, whereas KO of Atg14, a gene essential for canonical autophagy only (54), did not (Fig. 3 E and F and SI Appendix, Fig. S3 F and G).
Lastly, in canonical autophagy, the cargo becomes entrapped inside double-membrane structures termed autophagosomes, whereas in LAP, the target is engulfed into single-membraned phagosomes (41). We assessed vesicle membrane structure by transmission electron microscopy. Whereas vesicles in Rapa-treated BMDMs exhibited double membranes, only single-membrane structures, indicative of LAP phagosomes, were found to contain Zymo and S. pneumoniae in BMDMs treated with the respective stimuli (Fig. 3G and SI Appendix, Table S1). Together, these results suggest that S. pneumoniae triggers LAP, not canonical autophagy, in BMDMs.
LAP Promotes Clearance of S. pneumoniae.
LAP can result in delivery of microbes to lysosomes for subsequent degradation (38). We found that most LC3-positive S. pneumoniae vesicles also colocalized with lysosome-associated membrane protein 2 (LAMP-2) in BMDMs (Fig. 4A), indicating that this process often resulted in delivery of the bacteria to late endosomes or lysosomes. To determine whether LAP was important for killing internalized S. pneumoniae in BMDMs, we assessed S. pneumoniae survival in BMDMs and found that S. pneumoniae was killed in a time-dependent manner (Fig. 4B). To determine whether this killing was mediated by LAP, we evaluated S. pneumoniae killing in BMDMs lacking Atg14, Atg7, Rubicon, or Nox2. BMDMs lacking Atg14, which is required specifically for canonical autophagy, cleared S. pneumoniae as effectively as WT BMDMs (Fig. 4C). In contrast, those lacking Atg7, Rubicon, or Nox2 were defective in S. pneumoniae clearance (Fig. 4 D and E). ROS have antibacterial effects against S. pneumoniae independent of LAP (42, 57). However, we did not observe additional killing defects in in Nox2−/− BMDMs compared to LAP defective Rubicon−/− BMDMs (Fig. 4E). Although Rubicon−/− BMDMs are somewhat diminished in ROS production upon challenge with Zymo due to the role of Rubicon in stabilizing NOX2 NADPH oxidase (52), these results suggest that the primary mechanism of S. pneumoniae killing in BMDMs depends on ROS-mediated LAP rather than the direct bacteriocidal activity of ROS.
S. pneumoniae-Triggered LAP Is Impaired in Aged BMDMs.
Autophagic activities tend to decline with age (58). As the elderly population is especially susceptible for S. pneumoniae infection, we set out to examine whether BMDMs from young and aged mice differ in S. pneumoniae-triggered LAP. We transfected BMDMs isolated from young (2-mo old) and aged (20- to 22-mo old) with GFP-LC3 and confirmed that young and aged BMDMs displayed no difference in transfection efficiency or posttransfection cell viability (SI Appendix, Fig. S4). In addition, although S. pneumoniae has been reported to induce cytotoxicity in BMDMs upon extended (4-h) infection by an MOI of 100 (59), we confirmed no LDH release by young or aged BMDMs upon pneumococcal infection at an MOI of 50 for 80 min. Upon S. pneumoniae infection of GFP-LC3-expressing cells, colocalization was significantly higher in young BMDMs than aged BMDMs throughout the 3-h time course (Fig. 5 A and B). Immunoblotting for LC3 revealed a twofold increase in LC3-II conversion in S. pneumoniae-infected young BMDMs compared to uninfected control as early as 1.5-h postinfection, whereas infected aged BMDMs responded with no significant increase in LC3-II even after 3 h of infection (Fig. 5C). That both LC3 conversion and recruitment are significantly lower in aged BMDMs suggests that LAP is more efficiently triggered by S. pneumoniae infection in young BMDMs compared to aged BMDMs. This relative defect in S. pneumoniae-triggered LAP was not due to a defect in ROS production because young and aged BMDMs produced equivalent amounts (SI Appendix, Fig. S5).
To determine if the decline in LAP in aged BMDMs compromised the ability of aged BMDMs to kill internalized S. pneumoniae, we measured killing of S. pneumoniae by BMDMs from young or aged mice over time. Compared to young BMDMs, aged BMDMs were consistently less efficient at clearing S. pneumoniae over the 120-min period examined (Fig. 6A). We found that silencing of Rubicon in young BMDMs resulted in a twofold increase in the survival of S. pneumoniae, but had no effect on the ability of aged BMDMs to kill the bacterium (Fig. 6B), suggesting that LAP contributes to pneumococcal killing by young BMDM and that the relative defect of S. pneumoniae-induced LAP in aged BMDM is associated with a relative defect in bacterial killing.
LAP is immunomodulatory (39) and aging is associated with higher basal and induced levels of proinflammatory cytokines (28). In addition, in response to 24 h of infection by S. pneumoniae, aged mice produce higher levels of Il6, Tnf, and Il1b messenger RNA (mRNA) (35). We utilized qRT-PCR to quantitate the level of induction of these cytokine mRNAs upon a 90-min infection by S. pneumoniae in young or aged BMDMs that had been subjected to control small interfering RNA (siRNA) or Rubicon siRNA to diminish LAP. After infection, control siRNA-treated aged BMDMs produced higher levels of Il6, Tnf, and Il1b compared to control siRNA-treated young BMDMs, consistent with inflammaging. In young BMDMs infected with S. pneumoniae, inhibition of LAP by silencing of Rubicon increased cytokine production to levels indistinguishable from those of the aged BMDMs, indicating that LAP as predicted functions to diminish inflammatory cytokine gene expression. In contrast, LAP inhibition in aged BMDMs had no effect on the production of Il6, Tnf, or Il1b, consistent with our previous finding that BMDMs LAP is significantly diminished by aging (Fig. 7). PLY-deficient S. pneumoniae were found to induce levels of Il6, Tnf, and Il1b statistically indistinguishable from those induced by WT bacteria (53), a result we confirmed here (SI Appendix, Fig. S6), indicating that PLY deficiency may trigger alternate pathways of cytokine production that are not influenced by autophagic processes. Nevertheless, our findings with Rubicon siRNA indicate that the decline in a LAP response triggered by infection of aged BMDMs with WT S. pneumoniae not only reduced killing of S. pneumoniae, but also increased expression of genes encoding proinflammatory cytokines.
Discussion
In this study, we investigated the interaction of pneumococcus with BMDMs, which play a critical role in host defense against S. pneumoniae disease. We found that, upon infection of either murine BMDMs or a macrophage line, S. pneumoniae triggered LC3 recruitment in a manner dependent upon the pore-forming toxin PLY. In cultured epithelial cells and fibroblasts, S. pneumoniae has been shown to elicit autophagy in a PLY-dependent manner (44–46). Endosomal membrane disruption is one trigger for autophagy activation (60), and several other bacteria that produce membrane-damaging toxins, including Shigella flexneri, Salmonella enterica, Vibrio cholerae, Listeria monocytogenes, and Staphylococus aureus, induce autophagy (45, 61–64). Group A Streptococcus encodes streptolysin O (SLO), a cholesterol-dependent cytolysin highly related to PLY, that similarly triggers an autophagic process (65). Although PLY, unlike SLO (66), lacks a canonical secretion signal, it is localized to the bacterial surface and can also be released upon bacterial lysis (67–70). In BMDMs, we also found a role for PLY, but in this case, S. pneumoniae activated LAP. In addition, autophagy and autophagy-related processes can be activated by cell surface and endosomal pattern recognition receptors, such as Toll-like receptors (TLRs) (41, 71), and PLY (72) as well as other pneumococcal factors (6) have been reported to interact with TLR2 and TLR4. PLY binds to macrophages and dendritic cell mannose receptor C type I (73), a phagocytic receptor that is implicated in enhancing a number of macrophage antimicrobial functions, including autophagy (74). Whether PLY engagement of pattern recognition receptors contributes to LC3 trafficking pathways will require further investigation.
Several studies have indicated that in fibroblasts or epithelial cells, S. pneumoniae triggers a canonical autophagic process that requires factors, such as FIP200 and Ulk1, that are dispensable for LAP, and results in the engulfment of the bacterium in double-membrane autophagosomes (46, 51). Treatment of mice with Rapa to induce canonical autophagy results in modest protection from S. pneumoniae lung challenge but is not associated with reduced lung burden (75). We found that S. pneumoniae internalized into BMDMs colocalize with LC3 in a fashion requiring Atg5 and Atg7, two components of the autophagic machinery (48) that are required for both canonical autophagy and LAP. We developed evidence that in BMDMs, the pathogen triggers LAP rather than canonical autophagy. p70S6K, a substrate of mammalian target of Rapa (mTOR) and, hence, a protein that is dephosphorylated during metabolically regulated canonical autophagy, remained phosphorylated in S. pneumoniae-infected BMDMs. Although LC3 recruitment during LAP is reliant on several autophagy proteins, such as Atg5 and Atg7, it is characterized by its independence from components of the autophagy preinitiation complex, such as Ulk1, Atg13, and FIP200 (52), or components of the initiation complex for canonical autophagy, such as Atg14. We found that depletion of Ulk1 or FIP200, or depletion or genetic ablation of Atg14, had no effect on LC3 recruitment to S. pneumoniae, whereas depletion and/or ablation of autophagic components specific to LAP, such as Rubicon or Nox2, diminished LC3 recruitment more than twofold. Reflecting a functional role of the NADPH oxidase, S. pneumoniae-infected BMDMs generated ROS, a necessary step for LAP but not canonical autophagy, and chemical inhibition of ROS production blocked recruitment of LC3 to pneumococcus-containing phagosomes. Finally, internalized S. pneumoniae were sequestered within single- rather than double-membrane structures, consistent with LAP. Thus, pharmacological inhibition, genetic silencing and ablation, and morphological analyses indicate that S. pneumoniae trigger LAP in BMDMs.
A common method of assessing autophagy, particularly, before the widespread recognition of LAP as an important means of antimicrobial defense, has been the detection of pathogen-associated LC3 puncta (36). LC3 localization is associated with both LAP and canonical autophagy, and the emergence of facile methods to distinguish LAP from canonical autophagy only relatively recently raised the possibility that LAP occurs in cell types other than macrophages. For example, high levels of ROS are generated upon pneumococcal infection of A549 cells, and inhibition of ROS production decreases autophagy and enhances bacteria survival (51). In addition, in mouse embryo fibroblasts (MEFs), S. pneumoniae triggers canonical autophagy only after initially activating a process that resembles LAP in its independence of FIP200 and Ulk1 (47). However, this early LC3 trafficking in MEFs requires neither PI3 kinase activity nor ROS production, hallmarks of conventional LAP (48, 52). Furthermore, in contrast to the bacteriocidal process described here in BMDM (Fig. 4), MEF-mediated bacterial killing required further processing to autophagosomes by components of the canonical autophagic machinery, such as ATG14 (47). The relationship of the noncanonical autophagy pathway in MEFs to LAP in BMDMs described here and the mechanisms resulting in the disparate fates of internalized bacteria remain to be explored. The specialized phagocytic nature of macrophages, for example, in higher levels of NOX2 compared to fibroblasts (76), the degree of phagosomal acidification, or the production of serine proteases (77) or antimicrobial peptides (78) may result in their alternate autophagic responses and subsequent bacteriocidal efficacy (38).
Recruitment of inflammatory cells, including macrophages, to the lungs during S. pneumoniae infection is increased in aged compared to young mice (79) and is associated with greater bacterial burden, raising the possibility that aged macrophages may be compromised in both effector and immunomodulatory function. Autophagic capacity declines with age, contributing to many of the diseases associated with advanced age (58). A number of common age-related cellular senescence pathways, such as those that increase mitochondrial or endoplasmic reticulum stress, not only regulate autophagic processes by a myriad of mechanisms (80–82), but also have been shown to functionally impair macrophage responses to S. pneumoniae (35, 79, 83). Aging is associated with diminished expression of several autophagy proteins, including those, such as ATG5 and ATG7, that function in both canonical autophagy and LAP (54). We observed no striking difference in the level of Rubicon produced by young or aged BMDM (Fig. 6B); previous studies suggest that age-related differences in Rubicon expression may differ depending upon tissue type (84, 85). Regardless, in our functional studies, we found that S. pneumoniae-induced LAP, reflected in the conjugation of LC3 and its colocalization with ingested bacteria, diminished with age. Bacteriocidal activity was correspondingly compromised in aged BMDMs, and in contrast to young BMDMs, unaffected by LAP inhibition. Similarly, aged BMDMs were more highly inflammatory than young BMDMs, reflected in higher levels of proinflammatory cytokine expression after S. pneumoniae infection. The relatively muted inflammatory response of young compared to aged BMDMs was due to LAP because LAP inhibition enhanced their response. In contrast, the expression of inflammatory cytokines after infection of aged (and relatively LAP-deficient) BMDMs was unaffected by LAP inhibition.
Human monocyte-derived macrophages from frail elderly individuals exhibit a significant defect in controlling S. pneumoniae (86). The precise nature of this defect remains unclear, but LAP-mediated defense has been demonstrated to be critical to host defense against a variety of infectious agents, several of which cause more serious infection in aged individuals. For example, adults older than 65 y are at increased risk of serious food-borne illness caused by L. monocytogenes or S. enterica (87), two pathogens for which LAP functions to mitigate systemic infection (88–90). Moreover, the regulatory effect of LAP on production of proinflammatory cytokines would be predicted to modulate intestinal proliferation of S. enterica for which growth is metabolically promoted by a robust inflammatory response (91). Among other lung pathogens, Legionella pnemophila and Mycobacterium tuberculosis cause more severe illness in the aged (92, 93) and are capable of triggering LAP (94). Several of the above pathogens are capable of manipulating LAP or LAP-like pathways (61, 62, 95–97), a property that may render elderly individuals, who may have a preexisting partial defect in LAP, particularly, susceptible to these infections. Thus, our finding that LAP is an important innate immune defense employed by BMDMs to control both S. pneumoniae infection and concomitant inflammation, one that diminishes with age, may provide insight into to the age-related susceptibility to diverse microbial pathogens.
Materials and Methods
Reagents.
Rapa, 3-MA, DPI, and digitonin were obtained from Millipore Sigma.
Bacterial Strains and Mutants.
S. pneumoniae TIGR4 (serotype 4) was used as a WT strain in this study. The TIGR4 mutant strains, including Δcps, Δply, ΔpspA, and ΔpspC were provided by Professor A. Camilli (Tufts University, Boston, MA). The S. pneumoniae D39 (serotype 2), D39 mutant strain that lacks PLY (D39Δply), and D39Δply complemented with PLY (D39Δply ply comp) were described previously (24). These S. pneumoniae strains were grown as described in the SI Appendix, SI Materials and Methods.
Mice.
Young (2-mo) and aged (22–26-mo) male C57BL/6 mice were purchased from Charles River Laboratories and the National Institute on Aging rodent facility. Atg7flox/flox-LysM-Cre and Atg14flox/flox-LysM-Cre were generously provided by H. W. Virgin (Washington University School of Medicine [WUSM]). Rubicon−/− mice were provided by D. Young (St. Jude Children’s Research Hospital, Memphis, TN). Nox2-KO mice were provided by M. Dinauer (WUSM). All mice were maintained in a specific-pathogen free facility at Tufts University, Gifu University, and Washington University, and all procedures were performed in accordance with Institutional Animal Care and Use Committee guidelines. No animals were used in the study if they had evidence of visible skin lesions, weight loss, or lymphadenopathy.
BMDMs and Mouse RAW264.7 Cells.
The phenotype of BMDM induced to differentiate with granulocyte-macrophage colony-stimulating factor (GM-CSF) resembles that of macrophages recruited to lungs (98), and we harvested bone-marrow cells from the femurs and tibiae of male C57BL/6 mice, followed by incubation in differentiation medium, i.e., basal medium with GM-CSF. BMDMs and RAW264.7 cells (American Type Culture Collection) were grown as described in the SI Appendix, SI Materials and Methods.
Plasmids, siRNA, and Transfection.
pGFP-LC3 was a gift from T. Yoshimori (Addgene plasmid no. 21073) (99). Stealth predesigned siRNAs and the control nontargeting siRNA (negative control med GC) were acquired from Thermo Fisher Scientific. Transfection was performed as described in the SI Appendix, SI Materials and Methods.
Western Blotting.
Western blotting was performed as described in the SI Appendix, SI Materials and Methods.
Electron Microscopy.
Electron microscopy was performed as described in the SI Appendix, SI Materials and Methods.
Bacterial Killing Assay.
To measure BMDM killing of S. pneumoniae, 5 × 105 BMDMs were preincubated with an MOI of 10 bacteria per BMDM for 1 h at 37 °C with gentle inversion as outlined above to allow for internalization of bacteria (34). Viable colony-forming units were determined by culturing of supernatants on TS agar plates.
Immunofluorescence.
Cells (2 × 105 cells/well) were seeded on 4- or 8-well Permanox slides (Nunc Lab-Tek Chamber Slide System; Thermo Fisher Scientific). The following day, they were infected with S. pneumoniae at an MOI of 20 for 1 h, washed with phosphate-buffered saline (PBS) three times, and fixed with 4% paraformaldehyde in PBS for 10 min at 37 °C. To distinguish between intracellular and extracellular S. pneumoniae, extracellular and total bacteria were differentially stained as described previously (100). Immunostaining and image acquisition were performed as described in the SI Appendix, SI Materials and Methods.
Detection of ROS.
CellROX reagents for oxidative stress detection (C10448; Thermo Fisher Scientific) was performed according to the protocol.
RNA Isolation and qRT-PCR.
RNA isolation and qRT-PCR were performed as described in the SI Appendix, SI Materials and Methods.
Statistics.
Data are shown as the mean ± SEM. For single comparisons, P values were calculated using the Mann–Whitney U test or Student’s t test. For multiple comparisons, two-way ANOVA followed by a Bonferroni test or one-way ANOVA with Dunnett’s test were used. Differences with P < 0.05 were considered significant.
Supplementary Material
Acknowledgments
We thank Elsa Bou Ghanem, Sara Roggensack, Marcia Osburne, Nalat Siwapornchai, and Dawn Bowdish for helpful experimental advice and/or invaluable discussion in the preparation of the paper; H. W. Virgin (WUSM), M. Dinauer (WUSM), and D. Young (St. Jude Children’s Research Hospital, Memphis, TN) for their generosity in providing mice; Hitoshi Iwahashi (Gifu University) for mouse experiment cooperation; and Greg Hendricks and Lara Strittmatter at the UMass Medical School Electron Microscopy Core for technical advice. This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science to M.I. (18K09544), the Pott’s Memorial Foundation to P.C., and NIH/National Institute of Allergy and Infectious Diseases R01s (Grant AI087682, Grant AI130454) to J.A.P.
Footnotes
The authors declare no competing interest.
This article is a PNAS Direct Submission. C.R.R. is a guest editor invited by the Editorial Board.
This article contains supporting information online at https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2015368117/-/DCSupplemental.
Data Availability.
All study data are included in the article and supporting information.
References
- 1.Bogaert D., De Groot R., Hermans P. W., Streptococcus pneumoniae colonisation: The key to pneumococcal disease. Lancet Infect. Dis. 4, 144–154 (2004). [DOI] [PubMed] [Google Scholar]
- 2.van der Poll T., Opal S. M., Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 374, 1543–1556 (2009). [DOI] [PubMed] [Google Scholar]
- 3.Miyashita N., Yamauchi Y., Bacterial pneumonia in elderly Japanese populations. Jpn. Clin. Med. 9, 1179670717751433 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Xu J., Murphy S. L., Kochanek K. D., Bastian B., Arias E., Deaths: Final data for 2016. Natl. Vital Stat. Rep. 67, 1–76 (2018). [PubMed] [Google Scholar]
- 5.Cole J., Aberdein J., Jubrail J., Dockrell D. H., The role of macrophages in the innate immune response to Streptococcus pneumoniae and Staphylococcus aureus: Mechanisms and contrasts. Adv. Microb. Physiol. 65, 125–202 (2014). [DOI] [PubMed] [Google Scholar]
- 6.Koppe U., Suttorp N., Opitz B., Recognition of Streptococcus pneumoniae by the innate immune system. Cell. Microbiol. 14, 460–466 (2012). [DOI] [PubMed] [Google Scholar]
- 7.Krone C. L., Trzciński K., Zborowski T., Sanders E. A., Bogaert D., Impaired innate mucosal immunity in aged mice permits prolonged Streptococcus pneumoniae colonization. Infect. Immun. 81, 4615–4625 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Evans S. E., Ost D. E., Pneumonia in the neutropenic cancer patient. Curr. Opin. Pulm. Med. 21, 260–271 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Arredouani M., et al. , The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles. J. Exp. Med. 200, 267–272 (2004). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Arredouani M. S., et al. , The macrophage scavenger receptor SR-AI/II and lung defense against pneumococci and particles. Am. J. Respir. Cell Mol. Biol. 35, 474–478 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Sanders L. A., et al. , Fc gamma receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J. Infect. Dis. 170, 854–861 (1994). [DOI] [PubMed] [Google Scholar]
- 12.Weber S., Tian H., van Rooijen N., Pirofski L. A., A serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibody requires Fcγ receptor III and macrophages to mediate protection against pneumococcal pneumonia in mice. Infect. Immun. 80, 1314–1322 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Preston J. A., et al. , Alveolar macrophage apoptosis-associated bacterial killing helps prevent murine pneumonia. Am. J. Respir. Crit. Care Med. 200, 84–97 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Dockrell D. H., et al. , Alveolar macrophage apoptosis contributes to pneumococcal clearance in a resolving model of pulmonary infection. J. Immunol. 171, 5380–5388 (2003). [DOI] [PubMed] [Google Scholar]
- 15.Dockrell D. H., Whyte M. K. B., Mitchell T. J., Pneumococcal pneumonia: Mechanisms of infection and resolution. Chest 142, 482–491 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Taut K., et al. , Macrophage turnover kinetics in the lungs of mice infected with Streptococcus pneumoniae. Am. J. Respir. Cell Mol. Biol. 38, 105–113 (2008). [DOI] [PubMed] [Google Scholar]
- 17.Kafka D., et al. , Contribution of IL-1 to resistance to Streptococcus pneumoniae infection. Int. Immunol. 20, 1139–1146 (2008). [DOI] [PubMed] [Google Scholar]
- 18.Takashima K., et al. , Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice. Infect. Immun. 65, 257–260 (1997). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Xu F., et al. , Modulation of the inflammatory response to Streptococcus pneumoniae in a model of acute lung tissue infection. Am. J. Respir. Cell Mol. Biol. 39, 522–529 (2008). [DOI] [PubMed] [Google Scholar]
- 20.Calbo E., Garau J., Of mice and men: Innate immunity in pneumococcal pneumonia. Int. J. Antimicrob. Agents 35, 107–113 (2010). [DOI] [PubMed] [Google Scholar]
- 21.Sohail I., Ghosh S., Mukundan S., Zelewski S., Khan M. N., Role of inflammatory risk factors in the pathogenesis of Streptococcus pneumoniae. Front. Immunol. 9, 2275 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.José R. J., et al. , Regulation of neutrophilic inflammation by proteinase-activated receptor 1 during bacterial pulmonary infection. J. Immunol. 194, 6024–6034 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Bhowmick R., Clark S., Bonventre J. V., Leong J. M., McCormick B. A., Cytosolic phospholipase A2α promotes pulmonary inflammation and systemic disease during Streptococcus pneumoniae infection. Infect. Immun. 85, e00280-17 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Bhowmick R., et al. , Systemic disease during Streptococcus pneumoniae acute lung infection requires 12-lipoxygenase-dependent inflammation. J. Immunol. 191, 5115–5123 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Bou Ghanem E. N., et al. , Extracellular adenosine protects against Streptococcus pneumoniae lung infection by regulating pulmonary neutrophil recruitment. PLoS Pathog. 11, e1005126 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Daigneault M., et al. , Monocytes regulate the mechanism of T-cell death by inducing Fas-mediated apoptosis during bacterial infection. PLoS Pathog. 8, e1002814 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Knapp S., et al. , Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia. Am. J. Respir. Crit. Care Med. 167, 171–179 (2003). [DOI] [PubMed] [Google Scholar]
- 28.Franceschi C., et al. , Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 908, 244–254 (2000). [DOI] [PubMed] [Google Scholar]
- 29.Boyd A. R., Orihuela C. J., Dysregulated inflammation as a risk factor for pneumonia in the elderly. Aging Dis. 2, 487–500 (2011). [PMC free article] [PubMed] [Google Scholar]
- 30.Rea I. M., et al. , Age and age-related diseases: Role of inflammation triggers and cytokines. Front. Immunol. 9, 586 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Bruunsgaard H., Skinhøj P., Qvist J., Pedersen B. K., Elderly humans show prolonged in vivo inflammatory activity during pneumococcal infections. J. Infect. Dis. 180, 551–554 (1999). [DOI] [PubMed] [Google Scholar]
- 32.Bou Ghanem E. N., et al. , The alpha-tocopherol form of vitamin E boosts elastase activity of human PMNs and their ability to kill Streptococcus pneumoniae. Front. Cell. Infect. Microbiol. 7, 161 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Williams A. E., José R. J., Brown J. S., Chambers R. C., Enhanced inflammation in aged mice following infection with Streptococcus pneumoniae is associated with decreased IL-10 and augmented chemokine production. Am. J. Physiol. Lung Cell. Mol. Physiol. 308, L539–L549 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Thevaranjan N., et al. , Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction. Cell Host Microbe 21, 455–466.e4 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Cho S. J., Rooney K., Choi A. M. K., Stout-Delgado H. W., NLRP3 inflammasome activation in aged macrophages is diminished during Streptococcus pneumoniae infection. Am. J. Physiol. Lung Cell. Mol. Physiol. 314, L372–L387 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Keller M. D., Torres V. J., Cadwell K., Autophagy and microbial pathogenesis. Cell Death Differ. 27, 872–886 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Upadhyay S., Philips J. A., LC3-associated phagocytosis: Host defense and microbial response. Curr. Opin. Immunol. 60, 81–90 (2019). [DOI] [PubMed] [Google Scholar]
- 38.Herb M., Gluschko A., Schramm M., LC3-associated phagocytosis - the highway to hell for phagocytosed microbes. Semin. Cell Dev. Biol. 101, 68–76 (2020). [DOI] [PubMed] [Google Scholar]
- 39.Heckmann B. L., Boada-Romero E., Cunha L. D., Magne J., Green D. R., LC3-Associated phagocytosis and inflammation. J. Mol. Biol. 429, 3561–3576 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Mizushima N., Komatsu M., Autophagy: Renovation of cells and tissues. Cell 147, 728–741 (2011). [DOI] [PubMed] [Google Scholar]
- 41.Sanjuan M. A., et al. , Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 450, 1253–1257 (2007). [DOI] [PubMed] [Google Scholar]
- 42.Huang J., et al. , Activation of antibacterial autophagy by NADPH oxidases. Proc. Natl. Acad. Sci. U.S.A. 106, 6226–6231 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Henault J., et al. , Noncanonical autophagy is required for type I interferon secretion in response to DNA-immune complexes. Immunity 37, 986–997 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Li P., et al. , Streptococcus pneumoniae induces autophagy through the inhibition of the PI3K-I/Akt/mTOR pathway and ROS hypergeneration in A549 cells. PLoS One 10, e0122753 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Mathieu J., Interactions between autophagy and bacterial toxins: Targets for therapy? Toxins 7, 2918–2958 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Ogawa M., et al. , Molecular mechanisms of Streptococcus pneumoniae-targeted autophagy via pneumolysin, Golgi-resident Rab41, and Nedd4-1-mediated K63-linked ubiquitination. Cell. Microbiol. 20, e12846 (2018). [DOI] [PubMed] [Google Scholar]
- 47.Ogawa M., et al. , Streptococcus pneumoniae triggers hierarchical autophagy through reprogramming of LAPosome-like vesicles via NDP52-delocalization. Commun. Biol. 3, 25 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Lai S. C., Devenish R. J., LC3-Associated phagocytosis (LAP): Connections with host autophagy. Cells 1, 396–408 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Mizushima N., Yoshimori T., How to interpret LC3 immunoblotting. Autophagy 3, 542–545 (2007). [DOI] [PubMed] [Google Scholar]
- 50.Shu Z., et al. , Streptococcus pneumoniae PepO promotes host anti-infection defense via autophagy in a Toll-like receptor 2/4 dependent manner. Virulence 11, 270–282 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Martner A., Dahlgren C., Paton J. C., Wold A. E., Pneumolysin released during Streptococcus pneumoniae autolysis is a potent activator of intracellular oxygen radical production in neutrophils. Infect. Immun. 76, 4079–4087 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Martinez J., et al. , Molecular characterization of LC3-associated phagocytosis reveals distinct roles for Rubicon, NOX2 and autophagy proteins. Nat. Cell Biol. 17, 893–906 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 53.Bewley M. A., et al. , Pneumolysin activates macrophage lysosomal membrane permeabilization and executes apoptosis by distinct mechanisms without membrane pore formation. MBio 5, e01710–e01714 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Klionsky D. J., et al. , Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12, 1–222 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Matsunaga K., et al. , Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages. Nat. Cell Biol. 11, 385–396 (2009). [DOI] [PubMed] [Google Scholar]
- 56.Yang C. S., et al. , The autophagy regulator Rubicon is a feedback inhibitor of CARD9-mediated host innate immunity. Cell Host Microbe 11, 277–289 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Kim S. Y., et al. , Antibacterial strategies inspired by the oxidative stress and response networks. J. Microbiol. 57, 203–212 (2019). [DOI] [PubMed] [Google Scholar]
- 58.Vilchez D., Saez I., Dillin A., The role of protein clearance mechanisms in organismal ageing and age-related diseases. Nat. Commun. 5, 5659 (2014). [DOI] [PubMed] [Google Scholar]
- 59.González-Juarbe N., et al. , Pore-forming toxins induce macrophage necroptosis during acute bacterial pneumonia. PLoS Pathog. 11, e1005337 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Fujita N., et al. , Recruitment of the autophagic machinery to endosomes during infection is mediated by ubiquitin. J. Cell Biol. 203, 115–128 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Choy A., Roy C. R., Autophagy and bacterial infection: An evolving arms race. Trends Microbiol. 21, 451–456 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Mitchell G., et al. , Listeria monocytogenes triggers noncanonical autophagy upon phagocytosis, but avoids subsequent growth-restricting xenophagy. Proc. Natl. Acad. Sci. U.S.A. 115, E210–E217 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Mestre M. B., Fader C. M., Sola C., Colombo M. I., Alpha-hemolysin is required for the activation of the autophagic pathway in Staphylococcus aureus-infected cells. Autophagy 6, 110–125 (2010). [DOI] [PubMed] [Google Scholar]
- 64.von Muhlinen N., Thurston T., Ryzhakov G., Bloor S., Randow F., NDP52, a novel autophagy receptor for ubiquitin-decorated cytosolic bacteria. Autophagy 6, 288–289 (2010). [DOI] [PubMed] [Google Scholar]
- 65.Nakagawa I., et al. , Autophagy defends cells against invading group A Streptococcus. Science 306, 1037–1040 (2004). [DOI] [PubMed] [Google Scholar]
- 66.Bensi G., et al. , Multi high-throughput approach for highly selective identification of vaccine candidates: Tthe Group A Streptococcus case. Mol. Cell. Proteomics 11, M111.015693 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Walker J. A., Allen R. L., Falmagne P., Johnson M. K., Boulnois G. J., Molecular cloning, characterization, and complete nucleotide sequence of the gene for pneumolysin, the sulfhydryl-activated toxin of Streptococcus pneumoniae. Infect. Immun. 55, 1184–1189 (1987). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Price K. E., Greene N. G., Camilli A., Export requirements of pneumolysin in Streptococcus pneumoniae. J. Bacteriol. 194, 3651–3660 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Davis K. M., Akinbi H. T., Standish A. J., Weiser J. N., Resistance to mucosal lysozyme compensates for the fitness deficit of peptidoglycan modifications by Streptococcus pneumoniae. PLoS Pathog. 4, e1000241 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Korchev Y. E., et al. , A conserved tryptophan in pneumolysin is a determinant of the characteristics of channels formed by pneumolysin in cells and planar lipid bilayers. Biochem. J. 329, 571–577 (1998). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Delgado M. A., Deretic V., Toll-like receptors in control of immunological autophagy. Cell Death Differ. 16, 976–983 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Malley R., et al. , Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. U.S.A. 100, 1966–1971 (2003). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Subramanian K., et al. , Pneumolysin binds to the mannose receptor C type 1 (MRC-1) leading to anti-inflammatory responses and enhanced pneumococcal survival. Nat. Microbiol. 4, 62–70 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Jaynes J. M., et al. , Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses. Sci. Transl. Med. 12, eaax6337 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Hinojosa C. A., et al. , Enteric-delivered rapamycin enhances resistance of aged mice to pneumococcal pneumonia through reduced cellular senescence. Exp. Gerontol. 47, 958–965 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Brown D. I., Griendling K. K., Nox proteins in signal transduction. Free Radic. Biol. Med. 47, 1239–1253 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Standish A. J., Weiser J. N., Human neutrophils kill Streptococcus pneumoniae via serine proteases. J. Immunol. 183, 2602–2609 (2009). [DOI] [PubMed] [Google Scholar]
- 78.Scharf S., et al. , Streptococcus pneumoniae induces human β-defensin-2 and -3 in human lung epithelium. Exp. Lung Res. 38, 100–110 (2012). [DOI] [PubMed] [Google Scholar]
- 79.Mitzel D. N., Lowry V., Shirali A. C., Liu Y., Stout-Delgado H. W., Age-enhanced endoplasmic reticulum stress contributes to increased Atg9A inhibition of STING-mediated IFN-β production during Streptococcus pneumoniae infection. J. Immunol. 192, 4273–4283 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Lee J., Giordano S., Zhang J., Autophagy, mitochondria and oxidative stress: Cross-talk and redox signalling. Biochem. J. 441, 523–540 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Rashid H. O., Yadav R. K., Kim H. R., Chae H. J., ER stress: Autophagy induction, inhibition and selection. Autophagy 11, 1956–1977 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Senft D., Ronai Z. A., UPR, autophagy, and mitochondria crosstalk underlies the ER stress response. Trends Biochem. Sci. 40, 141–148 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Plataki M., et al. , Mitochondrial dysfunction in aged macrophages and lung during primary Streptococcus pneumoniae infection is improved with pirfenidone. Sci. Rep. 9, 971 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Nakamura S., et al. , Suppression of autophagic activity by Rubicon is a signature of aging. Nat. Commun. 10, 847 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Yamamuro T., et al. , Age-dependent loss of adipose Rubicon promotes metabolic disorders via excess autophagy. Nat. Commun. 11, 4150 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Verschoor C. P., Johnstone J., Loeb M., Bramson J. L., Bowdish D. M., Anti-pneumococcal deficits of monocyte-derived macrophages from the advanced-age, frail elderly and related impairments in PI3K-AKT signaling. Hum. Immunol. 75, 1192–1196 (2014). [DOI] [PubMed] [Google Scholar]
- 87.Scallan E., et al. , Bacterial enteric infections among older adults in the United States: Foodborne diseases active surveillance network, 1996-2012. Foodborne Pathog. Dis. 12, 492–499 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Gluschko A., et al. , The beta2 integrin Mac-1 induces protective LC3-associated phagocytosis of Listeria monocytogenes. Cell Host Microbe 23, 324–337.e325 (2018). [DOI] [PubMed] [Google Scholar]
- 89.Tan J. M. J., et al. , An ATG16L1-dependent pathway promotes plasma membrane repair and limits Listeria monocytogenes cell-to-cell spread. Nat. Microbiol. 3, 1472–1485 (2018). [DOI] [PubMed] [Google Scholar]
- 90.Masud S., van der Burg L., Storm L., Prajsnar T. K., Meijer A. H., Rubicon-dependent Lc3 recruitment to salmonella-containing phagosomes is a host defense mechanism triggered independently from major bacterial virulence factors. Front. Cell. Infect. Microbiol. 9, 279 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Winter S. E., et al. , Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 467, 426–429 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Rajagopalan S., Yoshikawa T. T., Tuberculosis in the elderly. Z. Gerontol. Geriatr. 33, 374–380 (2000). [DOI] [PubMed] [Google Scholar]
- 93.Sopena N., et al. , Community-acquired legionella pneumonia in elderly patients: Characteristics and outcome. J. Am. Geriatr. Soc. 55, 114–119 (2007). [DOI] [PubMed] [Google Scholar]
- 94.Abnave P., et al. , Screening in planarians identifies MORN2 as a key component in LC3-associated phagocytosis and resistance to bacterial infection. Cell Host Microbe 16, 338–350 (2014). [DOI] [PubMed] [Google Scholar]
- 95.Cheng M. I., Chen C., Engström P., Portnoy D. A., Mitchell G., Actin-based motility allows Listeria monocytogenes to avoid autophagy in the macrophage cytosol. Cell. Microbiol. 20, e12854 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Köster S., et al. , Mycobacterium tuberculosis is protected from NADPH oxidase and LC3-associated phagocytosis by the LCP protein CpsA. Proc. Natl. Acad. Sci. U.S.A. 114, E8711–E8720 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Choy A., et al. , The Legionella effector RavZ inhibits host autophagy through irreversible Atg8 deconjugation. Science 338, 1072–1076 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Akagawa K. S., et al. , Functional heterogeneity of colony-stimulating factor-induced human monocyte-derived macrophages. Respirology 11 (suppl.), S32–S36 (2006). [DOI] [PubMed] [Google Scholar]
- 99.Kabeya Y., et al. , LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19, 5720–5728 (2000). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Birmingham C. L., et al. , Listeria monocytogenes evades killing by autophagy during colonization of host cells. Autophagy 3, 442–451 (2007). [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All study data are included in the article and supporting information.